About 4D pharma
4D pharma is a company based in Manchester (United Kingdom) founded in 2008. The company has 106 employees as of December 31, 2021. 4D pharma has completed 2 acquisitions, including BIOMAR and GT Biologics. 4D pharma operates in a competitive market with competitors including Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
- Headquarter Manchester, United Kingdom
- Employees 106 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 4D Pharma Plc
- Date of Incorporation 10 Jan, 2014
- Jurisdiction LEEDS
-
Annual Revenue
$685.4 K (USD)153as on Dec 31, 2020
-
Net Profit
-$33.32 M (USD)-8as on Dec 31, 2020
-
EBITDA
Not available
-
Latest Funding Round
$24 M (USD), Post-IPO
Mar 17, 2021
-
Investors
Not available
-
Employee Count
106
as on Dec 31, 2021
-
Investments & Acquisitions
BIOMAR
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of 4D pharma
Investments & Acquisitions by 4D pharma
4D pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BIOMAR and GT Biologics.
Investment portfolio details for 4D pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing naturally occurring human bacteria as biotherapeutics for gastrointestinal diseases.
|
Locked | Locked | 2007 | Locked | |
|
Natural products from marine microorganisms are discovered and developed.
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for 4D pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - 4D pharma
Detailed financials for 4D pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
4D Pharma Comparisons
Peer comparison for 4D pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 4D pharma
4D pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for immunological and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
Detailed competitors of 4D pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 4D Pharma
Complete news archive for 4D pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 4D pharma
4D pharma was founded in 2008 and raised its 1st funding round 6 years after it was founded.
4D pharma is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
As of Dec 31, 2021, the latest employee count at 4D pharma is 106.
Annual revenue of 4D pharma is $685.4K as on Dec 31, 2020.
Founded in 2008 and based in Manchester, United Kingdom, the company operates in the biotechnology sector. Live biotherapeutic products are developed using the MicroRx platform, derived from gut bacteria. These products target diseases such as cancer, gastrointestinal disorders, respiratory conditions, and central nervous system ailments. Operations focus on research and development for therapeutic applications across these areas.
4D pharma's top competitors include Novozymes, BioNTech and Generate Biomedicines.
4D pharma has made 2 acquisitions, including BIOMAR, and GT Biologics.